Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment

Sorafenib is a multitargeted kinase inhibitor currently used in the treatment of advanced hepatocellular carcinoma (HCC). It is associated with a significant risk of skin toxicity, which nevertheless represents a clinical marker of good response to treatment. Hand-and-foot skin reaction, alopecia, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgia, Francesco, Saitta, Carlo, Vaccaro, Mario, Franzè, Maria Stella, Lentini, Maria, Cannavò, Serafinella Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815258/
https://www.ncbi.nlm.nih.gov/pubmed/28825507
http://dx.doi.org/10.1177/0394632017727618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815258/
https://www.ncbi.nlm.nih.gov/pubmed/28825507
http://dx.doi.org/10.1177/0394632017727618

Ejemplares similares